CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - 6 months ended Sep. 30, 2018 - USD ($) $ in Thousands	Total	Common Stock	Additional paid-in capital	Accumulated other comprehensive loss	Accumulated deficit	Equity attributable to Startek shareholders	Non-controlling interest
Beginning balance at Mar. 31, 2018	$ 194,145	$ 208	$ 153,702	$ (402)	$ (6,815)	$ 146,693	$ 47,452
Beginning balance (in shares) at Mar. 31, 2018	20,766,667	20,766,667
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Purchase accounting entries due to the Aegis Transactions	$ 141,885	$ 162	142,119	(396)		141,885
Purchase accounting entries due to the Aegis Transactions (in shares)		16,226,392
Common stock issued	116	$ 1	115			116
Common stock issued (in shares)		67,499
Share-based compensation	249		249			249
Changes to other comprehensive loss	(5,697)			(5,697)		(5,697)
Net loss	(14,664)				(14,609)	(14,609)	(55)
Ending balance at Sep. 30, 2018	$ 316,034	$ 371	$ 296,185	$ (6,495)	$ (21,425)	$ 268,636	$ 47,398
Ending balance (in shares) at Sep. 30, 2018	37,060,558	37,060,558